Literature DB >> 27673435

Behavior Therapy for Youth With Tourette Disorder.

Joseph F McGuire1.   

Abstract

Persistent tic disorders and Tourette disorder (TD) are neuropsychiatric conditions that commonly co-occur among youth with obsessive-compulsive disorder. Although historically managed with pharmacological agents such as antipsychotics and alpha-2 agonists, behavioral interventions like habit reversal training (HRT) and the comprehensive behavioral intervention for tics have demonstrated considerable efficacy in reducing tic symptom severity. This case study illustrates the implementation of behavior therapy in reducing tic symptom severity of an adolescent with TD. Arlene was a 14-year-old girl with TD who presented with moderate tic symptom severity that caused her physical, academic, and social impairment. In addition to concurrent pharmacotherapy, Arlene completed a 20-session weekly course of HRT, and experienced a clinically meaningful reduction in tic symptom severity and tic-related impairment. This example provides further evidence of the benefit of behavior therapy in reducing tic symptom severity and highlights key considerations for treatment of youth with TD.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Tourette disorder; behavior therapy; habit reversal training; tic disorders; treatment

Mesh:

Year:  2016        PMID: 27673435     DOI: 10.1002/jclp.22398

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  3 in total

1.  Correlation between premonitory urges and tic symptoms in a Chinese population with tic disorders.

Authors:  Yi Gu; Ying Li; Yonghua Cui
Journal:  Pediatr Investig       Date:  2020-06-24

Review 2.  Tourette Syndrome: A Mini-Review.

Authors:  Michal Novotny; Martin Valis; Blanka Klimova
Journal:  Front Neurol       Date:  2018-03-09       Impact factor: 4.003

3.  Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome.

Authors:  Deshuang Tao; Tangwu Zhong; Shuxia Ma; Jialin Li; Xiaojie Li
Journal:  Ann Gen Psychiatry       Date:  2019-10-10       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.